Dementias (Macintyre) Flashcards
Effect on Health Care
Alzheimer’s Dz now affects some 5 million Americans and 47 million people worldwide. U.S. residents ≥65yo living with Alzheimer’s is expected to nearly triple to 13.8 million by 2050 (est 135 million people living w/dementia by 2050)
Alzheimer’s Dz costs Americans $259 billion/yr. Expected to rise to up to $500 billion/yr by 2040 (sustainable economically??)
USA Today 3/19/2013: 1 out of 3 older adults dies with dementia.
Alzheimer’s deaths increased 68% from 2000-2010. Deaths from Alzheimer’s Dz nearly doubled in last 15 yrs. Alzheimer’s is 1 of 10 leading causes of death in US, 6th leading cause of death in the US, 5th leading cause of death between ages 65-85
NEJM April 2013: Dementia prevalence >70yo = 14.7%.
Washington Post Feb 2015: $1 trillion a year in costs by 2050
But wait…some good news from this year: prevalence of dementia in US fell from 11.6% to 8.8% from yrs 2000-2012 (role of education? Better CVD tx?) and recent research suggest age-specific dementia risk in high-income countries may be declining
EPIDEMIOLOGY
Some basic stats: 1.5% >65yo 16-25% >85yo Nearly 50% >90yo? 50-60% of dementias are Alzheimer’s 15-30% of dementias are Vascular NCD with Lewy Bodies approximately 20% of all dementias Remaining dementias: trauma, neurodegenerative, infectious, nutritional, metabolic, inflammatory, etc.
Major
Dementia
- not independent
Significant cognitive decline documented by knowledgeable reporter
Testing confirms significant impairment
Deficits interfere w/ADLs (not independent)
Not due to delirium or other mental d/o
Mild dementia
- can be independent
Modest cognitive decline documented by knowledgeable reporter
Testing confirms modest impairment
Deficits do not interfere w/ADLs (is independent)
Not due to delirium or other mental d/o
CHARACTERISTICS
Decline in cognitive domains:
- Complex attention
- Executive function (planning, organizing, abstracting, sequencing)
- Learning/memory
- Language
- Perceptual-motor
- Social cognition
Signs: aphasia (language disturbance); agnosia (inability to recognize); apraxia (inability to carry out motor activities)
** Progressive onset, steady course (important way to distinguish from delirium)
No clouding of consciousness (except NCD w/LB)
A WORD ABOUT NEUROTRANSMITTERS
Cholinergic neurons are lost through toxic damage or cell death decreased acetylcholine transmission
In all dementias, avoid anticholinergic meds
Acetylcholine is the major neurotransmitter addressed in dementia
Dopamine may play a role in some dementias
TYPICAL PRESENTATION
72yo female is brought to clinic because her family is worried about her. She is increasingly forgetful, leaves the stove on unattended, and wandered away from the house in the middle of the night last week, was very confused, but cleared the next day. She has had one or two “rage attacks” per the family. She is pleasant, cooperative, and states that there is nothing wrong with her but she appreciates her family’s concern.
neurocognitive disorders come in 2 flavors
dementia and delirium
avoid at all costs
anticholinergics
avoid them in the elderly anyway!
MEDICAL WORKUP
* Vital signs History & Physical Cognitive testing (MMSE, MOCA) Labs (Complete blood count, comprehensive metabolic profile, HIV/Syphilis tests, ammonia, thyroid, B12/Folate, Urinalysis, EKG, CXR) Neuroimaging when indicated
DIFFERENTIAL DX on our example lady
Delirium
Pseudodementia
Benign senescent forgetfulness (ie, normal aging)
Medical illness
REVERSIBLE DEMENTIAS
10-15% of dementias can be reversed if treated before reversible damage occurs
B12 deficiency, folate deficiency, infections, tumors, subdural hematoma, NPH (normal pressure hydrocephalus)
Focal neurological signs…?
MAJOR/MILD NCD DUE TO ALZHEIMER’S DISEASE
Most common cause of dementia
Dx at autopsy
Diffuse atrophy, enlarged ventricles
Fatal usually within 10 yrs
Focal neurological signs usu absent until late (if at all)
Risk factors: Down Syndrome (extra APP), female sex, hx head trauma, lower education level, ApoE alleles
Genetic component (possibly chromosomes 1, 14, 21)
***Apolipoprotein E: ε4 allele increases risk, ApoE ε2 is protective
Major NCD due to alzheimer’s disease
* not on exam
NCD criteria met
Probable: evidence of Alz Dz genetic mutation from testing or family hx OR evidence of clear decline in memory/learning & at least 1 other cognitive domain; steady/progressive cognitive decline; and, no evidence of any other cause.
Possible: “Probable” symptoms are not diagnosed
mild NCD due to alzheimer’s disease
* not on exam
NCD criteria met
Probable: evidence of genetic mutation or fam hx
Possible: no evidence of genetic mutation + evidence of clear decline in memory/learning & at least 1 other cognitive domain; steady/progressive cognitive decline; and, no evidence of any other cause.